NASDAQ
No price data available for this timeframe.
Corvus Pharmaceuticals, Inc. (CRVS) has a current ratio of 6.21x as of Monday, May 25, 2026. This represents a 45.81% increase compared to its 12-month average of 4.26x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.